Cite Filings / MLTX / 0001628280-23-023894

Feed Companies Filings Check

Sign in

424B5

Prospectus

MoonLake Immunotherapeutics Filed 2023-06-29 Acc 0001628280-23-023894

Documents 1

424B5 Prospectus , moonlake424b5-final.htm

Around this filing

2025-11-05 424B5 Prospectus
2023-06-30 SC 13D/A Beneficial Ownership Report
2023-06-29 8-K Material agreement · Other events
2023-06-29 424B5 Prospectus
2023-06-28 4 10% owner bought 450,000 shares at an average $45.63 ($20,535,012)
2023-06-27 424B3 Prospectus
2023-06-26 424B5 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading moonlake424b5-final.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…